Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis.

CONCLUSION: In hepatic cirrhosis, sclerostin is related to altered bone microarchitecture and lower areal BMD. In alcoholic liver disease, low sclerostin concentrations were seen. PMID: 31912287 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31912287?dopt=Abstract

Source: Wiener Klinische Wochenschrift - January 6, 2020 Category: General Medicine Authors: Wakolbinger R, Muschitz C, Wallwitz J, Bodlaj G, Feichtinger X, Schanda JE, Resch H, Baierl A, Pietschmann P Tags: Wien Klin Wochenschr Source Type: research